Filing Details
- Accession Number:
- 0001209191-19-044887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-06 18:45:59
- Reporting Period:
- 2019-08-02
- Accepted Time:
- 2019-08-06 18:45:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236927 | A Paul Friedman | 1801 Augustine Cut-Off Wilmington DE 19803 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-02 | 22,066 | $18.32 | 277,597 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-02 | 22,066 | $84.41 | 255,531 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-08-06 | 77,934 | $18.32 | 333,465 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-06 | 77,934 | $82.20 | 255,531 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-08-02 | 22,066 | $0.00 | 22,066 | $18.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-08-06 | 77,934 | $0.00 | 77,934 | $18.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 77,934 | 2020-02-08 | No | 4 | M | Direct | |
| 0 | 2020-02-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,000 | Indirect | By Grat |
| Common Stock | 15,000 | Indirect | By Grat |
| Common Stock | 15,000 | Indirect | By Grat |
| Common Stock | 15,000 | Indirect | By Grat |
Footnotes
- Represents weighted average sale price. Actual sale prices ranged from $84 - $84.92.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- Includes an aggregate of 1,520 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Shares were previously reported as directly beneficially owned but were contributed to a grantor retained annuity trust (GRAT) on April 3, 2019.
- Represents weighted average sale price. Actual sale prices ranged from $82.00 - $82.68.
- Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
